UCLA Medical GroupUCLA Medical Center Oncology 200 Ucla Medical Plz, Los Angeles, CA 90095 310-206-6909 (phone), 310-206-5507 (fax)
UCLA Medical GroupUCLA Santa Monica Hematology Oncology 2020 Santa Monica Blvd STE 600, Santa Monica, CA 90404 310-829-5471 (phone), 310-829-6192 (fax)
Education:
Medical School University of Southern California Keck School of Medicine Graduated: 1997
Procedures:
Chemotherapy
Conditions:
Leukemia Non-Hodgkin's Lymphoma Anemia Hemolytic Anemia Iron Deficiency Anemia
Languages:
English Russian
Description:
Dr. Finn graduated from the University of Southern California Keck School of Medicine in 1997. He works in Los Angeles, CA and 1 other location and specializes in Hematology/Oncology. Dr. Finn is affiliated with Ronald Reagan UCLA Medical Center and Santa Monica UCLA Medical Center.
North American Partners AnesthesiologyNorth American Partners 300 Community Dr FL 3, Manhasset, NY 11030 516-562-4887 (phone), 516-562-1664 (fax)
Education:
Medical School University of Massachusetts Medical School Graduated: 1983
Conditions:
Abdominal Aortic Aneurysm Abdominal Hernia Cholelethiasis or Cholecystitis Gastric Cancer Intestinal Obstruction
Languages:
English
Description:
Dr. Finn graduated from the University of Massachusetts Medical School in 1983. He works in Manhasset, NY and specializes in Anesthesiology. Dr. Finn is affiliated with Glen Cove Hospital, North Shore University Hospital, Northwell Health Long Island Jewish Medical Center and Staten Island University Hospital North.
funding to academic labs that took the lead in exploring the chemical's potential. Drs. Richard Finn at the UCLA Geffen School of Medicine and his colleague Dennis Slamon at the Revlon/UCLA Women's Cancer Research Program decided to see if Pfizer's compound would be effective against breast cancer.
Date: Feb 19, 2015
Category: Health
Source: Google
Pfizer's Palbociclib Delays Breast Cancer Progression By Nearly Two Years
"The curves are starting to separate ... It hasn't reached statistical significance, but patients are still being followed," said Dr. Richard Finn, associate professor of medicine at the University of California, Los Angeles, and a lead author of the study.
Date: Apr 07, 2014
Category: Health
Source: Google
Lilly Has Rival to Pfizer's Potential Breast Cancer Blockbuster
We took a new drug and asked how it works in a specificset of breast cancers based on science, said Richard Finn, anassociate professor at the University of California at LosAngeless Jonsson Comprehensive Cancer Center, and co-principalinvestigator of Pfizers study. This is really the type
Date: Apr 06, 2014
Category: Health
Source: Google
Pfizer Experimental Drug Slows Late-Stage Breast Cancer
The medicine is the first in a new class of agents thatworks by blocking a protein critical in the cancer cell cycle,said lead researcher Richard Finn. Its also among the mostpromising in New York-based Pfizers drug development pipeline,with the potential for generating $5 billion in annual sa